Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Cash from Investing Activities (2016 - 2026)

Intellia Therapeutics has reported Cash from Investing Activities over the past 12 years, most recently at $66.3 million for Q1 2026.

  • Quarterly Cash from Investing Activities fell 29.7% to $66.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $200.0 million through Mar 2026, down 6.53% year-over-year, with the annual reading at $228.0 million for FY2025, 81.6% up from the prior year.
  • Cash from Investing Activities was $66.3 million for Q1 2026 at Intellia Therapeutics, up from $27.5 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $151.6 million in Q4 2024 and troughed at -$122.2 million in Q1 2023.
  • The 5-year median for Cash from Investing Activities is $45.9 million (2023), against an average of $32.3 million.
  • Year-over-year, Cash from Investing Activities crashed 357.51% in 2023 and then surged 1498.51% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$30.2 million in 2022, then skyrocketed by 252.36% to $45.9 million in 2023, then skyrocketed by 229.93% to $151.6 million in 2024, then plummeted by 81.83% to $27.5 million in 2025, then soared by 140.83% to $66.3 million in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Cash from Investing Activities are $66.3 million (Q1 2026), $27.5 million (Q4 2025), and -$741000.0 (Q3 2025).